Skip to main content

Progress in Cancer Immunotherapy

  • Book
  • © 2016

Overview

  • Provides readers with recent progress in basic and clinical research of cancer immunotherapy
  • Covers hot topics in cancer immunotherapy, such as cancer vaccines, monoclonal antibodies and adoptive cellular therapy
  • Written by experts in this fields
  • Includes supplementary material: sn.pub/extras

Part of the book series: Advances in Experimental Medicine and Biology (AEMB, volume 909)

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (5 chapters)

Keywords

About this book

This book provides readers an extensive overview of recent progress in basic and clinical research on cancer immunotherapy. Thanks to rapid advances in molecular biology and immunology, it has become increasingly evident that cancer growth is influenced by host immune responses. With the success of a number of clinical trials, immunotherapy has become a promising treatment modality of cancer. This book covers five major topics, including monoclonal antibodies, biological response modifiers, cancer vaccines, adoptive cellular therapy and oncolytic viruses. It also examines the combination of different immune strategies as well as the combination of immunotherapy with other treatments to increase anti-tumor effects. Through the comprehensive discussion of the topic, the book sheds valuable new light on the treatment of tumors.

Editors and Affiliations

  • Dept. of Immunology, Cancer Inst & Hospi, Chinese Acad Med & Peking Med Coll, Beijing, China

    Shuren Zhang

About the editor

Dr. Shuren Zhang is a professor and the director of Department of Immunology, Cancer Institute & Hospital,Chinese Academy of Medical Sciences & Peking Union Medical College. He is the vice chairman of the society of Cancer Biotherapy of Chinese Anti-Cancer Association. His research focuses on tumor immunology and cancer immunotherapy, and he has published more than 60 research articles in this field.

Bibliographic Information

  • Book Title: Progress in Cancer Immunotherapy

  • Editors: Shuren Zhang

  • Series Title: Advances in Experimental Medicine and Biology

  • DOI: https://doi.org/10.1007/978-94-017-7555-7

  • Publisher: Springer Dordrecht

  • eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)

  • Copyright Information: The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature B.V. 2016

  • Hardcover ISBN: 978-94-017-7553-3Published: 06 June 2016

  • Softcover ISBN: 978-94-024-1379-3Published: 30 May 2018

  • eBook ISBN: 978-94-017-7555-7Published: 30 May 2016

  • Series ISSN: 0065-2598

  • Series E-ISSN: 2214-8019

  • Edition Number: 1

  • Number of Pages: XII, 283

  • Number of Illustrations: 1 b/w illustrations, 14 illustrations in colour

  • Topics: Human Genetics, Antibodies, Vaccine, Oncology

Publish with us